Related Experiment Video
Updated: Jun 3, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Medical therapy for systemic lupus erythematosus
Jason K Taylor1, Robert V McMurray
1Department of Medicine, University of Mississippi School of Medicine, Jackson 39216, USA. jktaylor@medicine.umsmed.edu
Journal of the Mississippi State Medical Association
|March 11, 2011
Summary
Systemic lupus erythematosus (SLE) requires multidisciplinary care. Understanding common drug classes, their side effects, and monitoring is crucial for effective SLE treatment and patient management.
Area of Science:
- Rheumatology
- Clinical Pharmacology
Background:
- Systemic lupus erythematosus (SLE) presents with diverse clinical manifestations, necessitating input from various medical specialties.
- Effective management of SLE requires comprehensive knowledge of its therapeutic agents, including indications, adverse effects, and toxicity monitoring.
Purpose of the Study:
- To outline the key pharmacological classes used in SLE treatment.
- To emphasize the importance of understanding drug profiles for healthcare providers managing lupus patients.
Main Methods:
- Review of common pharmacological agents for SLE.
- Categorization of therapies into four primary drug classes.
Main Results:
- Pharmacological therapy is tailored to SLE manifestation type and severity.
- Key drug classes include non-steroidal anti-inflammatory drugs, antimalarials, corticosteroids, and immunosuppressives/cytoxics.
Conclusions:
- A thorough understanding of SLE medications is vital for all clinicians involved in patient care.
- Appropriate selection and monitoring of therapies are essential for optimizing outcomes in SLE management.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...